An update on recruitment for the Fox Insights Parkinson's research initiative.

23andMe's Parkinson's research community manager, Paul Cannon shares his experience with Deep Brain Stimulation to treat his Parkinson's symptoms.

As part of a broad collaboration with the Michael J. Fox Foundation, 23andMe is inviting participants in its Parkinson's Research community to participate in a new initiative called Fox Insights to make data broadly available to qualified researchers worldwide starting in 2018, with the goals of sparking innovation and discoveries around Parkinson’s disease.

Participants in the 23andMe Parkinson’s disease research initiative have contributed a vast amount of data, that has enabled our researchers and collaborators to improve our understanding of the genetics of...

Scientists at 23andMe and Genentech have identified 17 new genetic variants associated with Parkinson’s disease, almost doubling the total number of known risk variants for the condition, which gives scientists hints at potential new targets for drugs to treat the disease.

23andMe recently started offering customers new Genetic Health Risk reports that have received FDA authorization. Below we’ve highlighted some important features in these reports to help you get more out...

April is Parkinson’s Awareness Month and this year it also marks the eighth anniversary of 23andMe’s Parkinson’s Research Community, which introduced a game-changing model for science, one that leverages online...

The U.S. Food and Drug Administration granted 23andMe authorization to offer ten genetic health risk reports including late-onset Alzheimer’s disease, Parkinson’s disease, celiac disease, and a condition associated with harmful...

Attending the annual American Society of Human Genetics meeting in Vancouver next week?We’d love to hear from you! Attend our talks, come by our posters, and find us at our...

After four days in Berlin attending the massive annual meeting of the International Parkinson’s and Movement Disorders Society, 23andMe Parkinson’s Community manager, Paul Cannon, PhD, came back hopeful for the...